A citation-based method for searching scientific literature

Masayuki Sekine, Koji Nishino, Takayuki Enomoto. Cancers (Basel) 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Prevalence and clinical correlations of BRCA1/BRCA2 unclassified variant carriers among unselected primary ovarian cancer cases - preliminary report.
Ewa J Majdak, Geertruida H De Bock, Izabela Brozek, Magdalena Perkowska, Karolina Ochman, Jaroslaw Debniak, Tomasz Milczek, Cees J Cornelisse, J Jassem, Janusz Emerich,[...]. Eur J Cancer 2005
19
100

Inherited Mutations in Women With Ovarian Carcinoma.
Barbara M Norquist, Maria I Harrell, Mark F Brady, Tom Walsh, Ming K Lee, Suleyman Gulsuner, Sarah S Bernards, Silvia Casadei, Qian Yi, Robert A Burger,[...]. JAMA Oncol 2016
335
100

The association of BRCA1 and BRCA2 mutations with prostate cancer risk, frequency, and mortality: A meta-analysis.
Mok Oh, Nasser Alkhushaym, Saad Fallatah, Abdulhamid Althagafi, Rana Aljadeed, Yazed Alsowaida, Joanne Jeter, Jennifer R Martin, Hani M Babiker, Ali McBride,[...]. Prostate 2019
21
100

Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.
Nasim Mavaddat, Susan Peock, Debra Frost, Steve Ellis, Radka Platte, Elena Fineberg, D Gareth Evans, Louise Izatt, Rosalind A Eeles, Julian Adlard,[...]. J Natl Cancer Inst 2013
482
100

Ovarian cancer in BRCA1/2 mutation carriers: The impact of mutation position and family history on the cancer risk.
Natalia Teixeira, Marian J E Mourits, Janet R Vos, Dorina M van der Kolk, Liesbeth Jansen, Jan C Oosterwijk, Geertruida H de Bock. Maturitas 2015
4
100

Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects.
Orland Díez, Ana Osorio, Mercedes Durán, José Ignacio Martinez-Ferrandis, Miguel de la Hoya, Raquel Salazar, Ana Vega, Berta Campos, Raquel Rodríguez-López, Eladio Velasco,[...]. Hum Mutat 2003
132
100

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.
Huong D Meeks, Honglin Song, Kyriaki Michailidou, Manjeet K Bolla, Joe Dennis, Qin Wang, Daniel Barrowdale, Debra Frost, Lesley McGuffog, Steve Ellis,[...]. J Natl Cancer Inst 2015
59
100

BRCA mutated pancreatic cancer: A change is coming.
Michael N Rosen, Rachel A Goodwin, Michael M Vickers. World J Gastroenterol 2021
1
100

Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel.
Nadine Tung, Chiara Battelli, Brian Allen, Rajesh Kaldate, Satish Bhatnagar, Karla Bowles, Kirsten Timms, Judy E Garber, Christina Herold, Leif Ellisen,[...]. Cancer 2015
252
100

Is uterine papillary serous adenocarcinoma a manifestation of the hereditary breast-ovarian cancer syndrome?
R Goshen, W Chu, L Elit, T Pal, J Hakimi, I Ackerman, A Fyles, M Mitchell, S A Narod. Gynecol Oncol 2000
96
100

The first Japanese nationwide multicenter study of BRCA mutation testing in ovarian cancer: CHARacterizing the cross-sectionaL approach to Ovarian cancer geneTic TEsting of BRCA (CHARLOTTE).
Takayuki Enomoto, Daisuke Aoki, Kana Hattori, Masahisa Jinushi, Junzo Kigawa, Nobuhiro Takeshima, Hitoshi Tsuda, Yoh Watanabe, Kosuke Yoshihara, Toru Sugiyama. Int J Gynecol Cancer 2019
31
100

BRCA1 and BRCA2 mutation prevalence and clinical characteristics of a population-based series of ovarian cancer cases from Denmark.
Marie Soegaard, Susanne Kruger Kjaer, Mark Cox, Eva Wozniak, Estrid Høgdall, Claus Høgdall, Jan Blaakaer, Ian J Jacobs, Simon A Gayther, Susan J Ramus. Clin Cancer Res 2008
72
100

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
783
100

BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients.
A Petrij-Bosch, T Peelen, M van Vliet, R van Eijk, R Olmer, M Drüsedau, F B Hogervorst, S Hageman, P J Arts, M J Ligtenberg,[...]. Nat Genet 1997
348
100

Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation.
S A Gayther, W Warren, S Mazoyer, P A Russell, P A Harrington, M Chiano, S Seal, R Hamoudi, E J van Rensburg, A M Dunning,[...]. Nat Genet 1995
424
100

Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.
Harvey A Risch, John R McLaughlin, David E C Cole, Barry Rosen, Linda Bradley, Isabel Fan, James Tang, Song Li, Shiyu Zhang, Patricia A Shaw,[...]. J Natl Cancer Inst 2006
438
100

Ovarian cancer: epidemiology and risk factors.
Carlo La Vecchia. Eur J Cancer Prev 2017
103
100

The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations. A prospective study.
Mario E Beiner, Amy Finch, Barry Rosen, Jan Lubinski, Pal Moller, Parviz Ghadirian, Henry T Lynch, Eitan Friedman, Ping Sun, Steven A Narod. Gynecol Oncol 2007
82
100

Analysis of clinical characteristics of breast cancer patients with the Japanese founder mutation BRCA1 L63X.
Reiko Yoshida, Chie Watanabe, Shiro Yokoyama, Mayuko Inuzuka, Junko Yotsumoto, Masami Arai, Seigo Nakamura. Oncotarget 2019
4
100

A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes.
Saundra S Buys, John F Sandbach, Amanda Gammon, Gayle Patel, John Kidd, Krystal L Brown, Lavania Sharma, Jennifer Saam, Johnathan Lancaster, Mary B Daly. Cancer 2017
168
100

Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.
K Metcalfe, S Gershman, H T Lynch, P Ghadirian, N Tung, C Kim-Sing, O I Olopade, S Domchek, J McLennan, A Eisen,[...]. Br J Cancer 2011
116
100

BRCA1 and BRCA2 mutations in the ovarian cancer population across race and ethnicity: special reference to Asia.
Santhanam Shanmughapriya, Vasanthi Nachiappan, Kalimuthusamy Natarajaseenivasan. Oncology 2013
20
100

Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies.
A C Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, H Olsson, O Johannsson, A Borg, B Pasini,[...]. J Med Genet 2005
105
100

BRCA1 and BRCA2 mutations and clinical interpretation in 398 ovarian cancer patients: comparison with breast cancer variants in a similar population.
Florencia C Cardoso, Susana Goncalves, Pablo G Mele, Natalia C Liria, Leonardo Sganga, Ignacio Diaz Perez, Ernesto J Podesta, Angela R Solano. Hum Genomics 2018
9
100

Cancer Incidence in BRCA1 mutation carriers.
Deborah Thompson, Douglas F Easton. J Natl Cancer Inst 2002
707
100

Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Mary B Daly, Tuya Pal, Michael P Berry, Saundra S Buys, Patricia Dickson, Susan M Domchek, Ahmed Elkhanany, Susan Friedman, Michael Goggins, Mollie L Hutton,[...]. J Natl Compr Canc Netw 2021
21
100

Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1).
Philipp Harter, Jan Hauke, Florian Heitz, Alexander Reuss, Stefan Kommoss, Frederik Marmé, André Heimbach, Katharina Prieske, Lisa Richters, Alexander Burges,[...]. PLoS One 2017
42
100

Risk of breast cancer in male BRCA2 carriers.
D G R Evans, I Susnerwala, J Dawson, E Woodward, E R Maher, F Lalloo. J Med Genet 2010
56
100

Reclassification of BRCA1 and BRCA2 variants found in ovarian epithelial, fallopian tube, and primary peritoneal cancers.
Hyeong In Ha, Jin Sun Ryu, Hyoeun Shim, Sun Young Kong, Myong Cheol Lim. J Gynecol Oncol 2020
1
100

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.
H A Risch, J R McLaughlin, D E Cole, B Rosen, L Bradley, E Kwan, E Jack, D J Vesprini, G Kuperstein, J L Abrahamson,[...]. Am J Hum Genet 2001
712
100

The Icelandic founder mutation BRCA2 999del5: analysis of expression.
Evgenia K Mikaelsdottir, Sigridur Valgeirsdottir, Jorunn E Eyfjord, Thorunn Rafnar. Breast Cancer Res 2004
35
100

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
100

Cancer variation associated with the position of the mutation in the BRCA2 gene.
Jan Lubinski, Catherine M Phelan, Parviz Ghadirian, Henry T Lynch, Judy Garber, Barbara Weber, Nadine Tung, Douglas Horsman, Claudine Isaacs, Alvaro N A Monteiro,[...]. Fam Cancer 2004
70
100

One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in Southern Sweden.
S Malander, M Ridderheim, A Måsbäck, N Loman, U Kristoffersson, H Olsson, M Nilbert, A Borg. Eur J Cancer 2004
68
100

Localization of a novel susceptibility gene for familial ovarian cancer to chromosome 3p22-p25.
M Sekine, H Nagata, S Tsuji, Y Hirai, S Fujimoto, M Hatae, I Kobayashi, T Fujii, I Nagata, K Ushijima,[...]. Hum Mol Genet 2001
18
100

Decreased prostate cancer-specific survival of men with BRCA2 mutations from multiple breast cancer families.
Heather Thorne, Amber J Willems, Eveline Niedermayr, Ivan M Y Hoh, Jason Li, David Clouston, Gillian Mitchell, Stephen Fox, John L Hopper, Damien Bolton. Cancer Prev Res (Phila) 2011
76
100

Treatment of endometriosis in different ethnic populations: a meta-analysis of two clinical trials.
Christoph Gerlinger, Thomas Faustmann, Jeffrey J Hassall, Christian Seitz. BMC Womens Health 2012
16
100

Multigene Panels to Evaluate Hereditary Cancer Risk: Reckless or Relevant?
Michael J Hall, Elias Obeid, Mary B Daly. J Clin Oncol 2016
8
100

Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families.
P N Tonin, A M Mes-Masson, P A Futreal, K Morgan, M Mahon, W D Foulkes, D E Cole, D Provencher, P Ghadirian, S A Narod. Am J Hum Genet 1998
127
100

Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation.
B Modan, P Hartge, G Hirsh-Yechezkel, A Chetrit, F Lubin, U Beller, G Ben-Baruch, A Fishman, J Menczer, J P Struewing,[...]. N Engl J Med 2001
237
100

BRCA1 and BRCA2 mutations among 233 unselected Finnish ovarian carcinoma patients.
L Sarantaus, P Vahteristo, E Bloom, A Tamminen, L Unkila-Kallio, R Butzow, H Nevanlinna. Eur J Hum Genet 2001
43
100

BRCA2, but not BRCA1, mutations account for familial ovarian cancer in Iceland: a population-based study.
Thorunn Rafnar, Kristrun R Benediktsdottir, Bjarki J Eldon, Thorgeir Gestsson, Hafsteinn Saemundsson, Karl Olafsson, Anna Salvarsdottir, Eirikur Steingrimsson, Steinunn Thorlacius. Eur J Cancer 2004
34
100

The role of BRCA2 in replication-coupled DNA interstrand cross-link repair in vitro.
Lubos Cipak, Norifumi Watanabe, Tadayoshi Bessho. Nat Struct Mol Biol 2006
39
100

Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene.
S A Gayther, J Mangion, P Russell, S Seal, R Barfoot, B A Ponder, M R Stratton, D Easton. Nat Genet 1997
333
100

Precision medicine for hereditary tumors in gynecologic malignancies.
Masayuki Sekine, Takayuki Enomoto. J Obstet Gynaecol Res 2021
1
100

Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study.
Marthe M de Jonge, Cornelis D de Kroon, Denise J Jenner, Jan Oosting, Joanne A de Hullu, Marian J E Mourits, Encarna B Gómez Garcia, Margreet G E M Ausems, J Margriet Collée, Klaartje van Engelen,[...]. J Natl Cancer Inst 2021
4
100

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.
Timothy R Rebbeck, Nandita Mitra, Fei Wan, Olga M Sinilnikova, Sue Healey, Lesley McGuffog, Sylvie Mazoyer, Georgia Chenevix-Trench, Douglas F Easton, Antonis C Antoniou,[...]. JAMA 2015
235
100

Germline BRCA1 mutations increase prostate cancer risk.
D Leongamornlert, N Mahmud, M Tymrakiewicz, E Saunders, T Dadaev, E Castro, C Goh, K Govindasami, M Guy, L O'Brien,[...]. Br J Cancer 2012
165
100

A Population-Based Study of Genes Previously Implicated in Breast Cancer.
Chunling Hu, Steven N Hart, Rohan Gnanaolivu, Hongyan Huang, Kun Y Lee, Jie Na, Chi Gao, Jenna Lilyquist, Siddhartha Yadav, Nicholas J Boddicker,[...]. N Engl J Med 2021
39
100

BRCA1 and BRCA2 mutations among ovarian cancer patients from Colombia.
Alexandra Ortiz Rodríguez, Marcia Llacuachaqui, Gonzalo Guevara Pardo, Robert Royer, Garrett Larson, Jeffrey N Weitzel, Steven A Narod. Gynecol Oncol 2012
44
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.